{
  "symbol": "EW",
  "name": "Edwards Lifesciences",
  "sector": "Health Care",
  "industry": "Health Care Equipment",
  "date_added": "2011-04-01",
  "headquarters": "Irvine, California",
  "founded": "1958",
  "market_cap": 44769.312768,
  "pe_ratio": 31.53719,
  "forward_pe": 31.15102,
  "eps": 2.42,
  "revenue": 5522.299904,
  "profit_margin": 0.75706,
  "debt_to_equity": 6.863,
  "return_on_equity": 0.16511999,
  "dividend_yield": null,
  "current_price": 76.31999969482422,
  "year_high": 95.25,
  "year_low": 58.93000030517578,
  "price_change_1d": -0.09163463199831412,
  "price_change_1w": -1.1142790968528797,
  "price_change_1m": -1.8644683179004127,
  "description": "Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for",
  "website": "https://www.edwards.com",
  "employees": 15800,
  "exchange": "NYQ",
  "currency": "USD",
  "analyst_target_price": 81.00586,
  "recommendation": 2.3125,
  "number_of_analysts": 29,
  "earnings_history": [],
  "analyst_data": {
    "target_high": 95.0,
    "target_low": 61.0,
    "target_mean": 81.00586,
    "target_median": 80.0
  },
  "last_updated": "2025-07-09T11:20:56.587491",
  "data_quality": {
    "has_financial_data": true,
    "has_earnings_data": false,
    "has_analyst_data": true,
    "completeness_score": 0.6666666666666666
  }
}